- HealthWarehouse.com, Inc. (HEWA, Financial) reports $15 million in net sales for Q1 2025, reflecting a 194% increase year-over-year.
- The company achieved a net income of $178,000, marking a shift from a net loss in the previous year.
- Adjusted EBITDA rose to $521,000, up significantly from $90,000 in Q1 2024.
HealthWarehouse.com, Inc. (HEWA), a prominent player in the healthcare e-commerce sector, has announced robust financial results for the first quarter of 2025, which ended on March 31. The company reported net sales of $15 million, signifying a remarkable 194% increase from the same period in 2024. This growth is primarily attributed to a 616% surge in partner services revenues.
Prescription sales soared to $14.4 million from $4.4 million, representing a 226.5% rise. However, sales in the direct-to-consumer (B2C) segment experienced a decline of 25.7%, amounting to $722,000 less than the previous year due to reduced advertising expenditure.
Gross profit for Q1 2025 reached $4.5 million, up by 53.5% from the prior year. Despite the increase in sales, the gross margin percentage dropped to 30.2% from 57.8%, largely due to competitive pressures in the B2B prescription business.
Operating expenses climbed by 36.5%, totaling $4.3 million, influenced by increased shipping and salary costs. The company's dedication to enhancing its service capabilities and expanding its technology infrastructure contributed to these higher expenses.
HealthWarehouse.com recorded a net income of $178,000 for the quarter, a significant turnaround from a net loss of $252,000 in Q1 2024. Adjusted EBITDA also improved substantially to $521,000 compared to $90,000 in the previous year, illustrating the economic scalability of the company’s business model.
The company's CEO, Joseph Peters, emphasized the ongoing investment in proprietary technology and operational efficiency to maintain its leadership in the healthcare e-commerce market. HealthWarehouse.com, recognized as an Approved Digital Pharmacy by the National Association of Boards of Pharmacy, continues to focus on increasing access to affordable healthcare nationwide.
